Novartis to buy U.S.-based biotech CoStim for undisclosed price
ZURICH (Reuters) - Novartis said it will buy U.S.-based CoStim Pharmaceuticals Inc., a privately held biotechnology company focused on harnessing the ...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/LlfVkebCuUA/story01.htm
No comments:
Post a Comment